NO176798C - Syntetisk peptid for påvisning av AIDS, fremgangsmåte for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, testsett for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, ARC og pre-AIDS tilstander - Google Patents

Syntetisk peptid for påvisning av AIDS, fremgangsmåte for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, testsett for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, ARC og pre-AIDS tilstander

Info

Publication number
NO176798C
NO176798C NO861697A NO861697A NO176798C NO 176798 C NO176798 C NO 176798C NO 861697 A NO861697 A NO 861697A NO 861697 A NO861697 A NO 861697A NO 176798 C NO176798 C NO 176798C
Authority
NO
Norway
Prior art keywords
aids
diagnosis
antibodies against
detection
against hiv
Prior art date
Application number
NO861697A
Other languages
English (en)
Norwegian (no)
Other versions
NO861697L (no
NO176798B (no
Inventor
Chang Yi Wang
James Jian Guang Wang
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/847,102 external-priority patent/US4735896A/en
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of NO861697L publication Critical patent/NO861697L/no
Publication of NO176798B publication Critical patent/NO176798B/no
Publication of NO176798C publication Critical patent/NO176798C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO861697A 1985-09-11 1986-04-29 Syntetisk peptid for påvisning av AIDS, fremgangsmåte for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, testsett for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, ARC og pre-AIDS tilstander NO176798C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77464485A 1985-09-11 1985-09-11
US83756686A 1986-03-04 1986-03-04
US06/847,102 US4735896A (en) 1986-03-04 1986-04-02 Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions

Publications (3)

Publication Number Publication Date
NO861697L NO861697L (no) 1987-03-12
NO176798B NO176798B (no) 1995-02-20
NO176798C true NO176798C (no) 1995-05-31

Family

ID=27419712

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861697A NO176798C (no) 1985-09-11 1986-04-29 Syntetisk peptid for påvisning av AIDS, fremgangsmåte for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, testsett for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, ARC og pre-AIDS tilstander

Country Status (9)

Country Link
EP (1) EP0214709B1 (fr)
JP (1) JP2702911B2 (fr)
AU (1) AU579467B2 (fr)
DE (2) DE214709T1 (fr)
DK (1) DK198086A (fr)
ES (1) ES8801839A1 (fr)
HK (1) HK95194A (fr)
IL (1) IL78696A (fr)
NO (1) NO176798C (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
JPS63501716A (ja) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ 合成ペプチドおよびａｉｄｓおよびａｒｃの診断ならびにワクチン注射へのその使用
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
AU7234387A (en) * 1986-03-24 1987-10-20 Ortho Pharmaceutical Corporation Synthetic htlv-iii peptides, compositions and uses thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0247557B1 (fr) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag Peptides enveloppé HTLV-III(LAV)
US5017688A (en) * 1986-06-12 1991-05-21 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
US4943627A (en) * 1986-06-12 1990-07-24 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
DK169582B1 (da) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant
AU7786387A (en) * 1986-07-21 1988-02-10 Southwest Foundation For Biomedical Research Composition of matter and method of immunizing against viral causative agents of aids and arc
FR2610632B1 (fr) * 1987-02-11 1990-12-21 Pasteur Institut Peptides caracteristiques des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida
CA1341436C (fr) * 1987-03-25 2003-08-05 Wesley L. Cosand Antigenes de synthese servant a la detection du syndrome (apparente au sida) cause par le virus lav-2
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
AU1711888A (en) * 1987-04-24 1988-12-02 Biogen, Inc. Immunotherapeutic methods and compositions
US4921787A (en) * 1987-05-01 1990-05-01 Cambridge Bioscience Corporation Detection of antibodies to human immunodeficiency virus by agglutination of antigen coated latex
US5854400A (en) * 1987-05-29 1998-12-29 Tanox, Inc. Monoclonal antibodies which neutralize HIV-1 infection
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
CA1339857C (fr) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Anticorps monoclonaux qui peuvent se fixer a la proteine gp120 et qui neutralisent le vih-1
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (fr) * 1987-12-24 1990-07-25 The University Of Melbourne Composés antiviraux et méthodes
SE8705197D0 (sv) * 1987-12-30 1987-12-30 Jonas Blomberg New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
US5149623A (en) * 1988-02-09 1992-09-22 Virotest, Inc. Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus
EP0330359A3 (fr) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition utile pour le diagnostic et le traitement de l'infection par le HIV-I
AU608413B2 (en) * 1988-03-30 1991-03-28 Abbott Laboratories Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Ｈｉｖ構成蛋白に対するモノクローナル抗体
IL94558A0 (en) * 1989-06-06 1991-03-10 Merck & Co Inc Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
IL95738A (en) * 1989-09-23 1996-11-14 Hoechst Ag Antibodies against the well-preserved amino acid sequences of insulin, a process for their preparation and use in immunoassay
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
ATE164853T1 (de) * 1990-01-16 1998-04-15 Orgenics Ltd Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
DK0489968T3 (da) * 1990-12-14 1997-03-24 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US7119182B1 (en) 1991-02-19 2006-10-10 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
CA2567813C (fr) 2004-05-23 2015-11-24 Gerard M. Housey Modulateurs de theramuteine
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
CN102146116B (zh) * 2010-12-30 2013-02-13 桂林医学院 罗汉果甜苷v特异性抗血清的制备及检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
US5063150A (en) * 1984-09-19 1991-11-05 The Regents Of The University Of California Retroviral polypeptides associated with human cellular transformation
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
WO1986006414A1 (fr) * 1985-04-29 1986-11-06 Genetic Systems Corporation Antigenes synthetiques permettant la detection d'une infection apparentee au sida

Also Published As

Publication number Publication date
JP2702911B2 (ja) 1998-01-26
EP0214709A3 (en) 1988-09-21
AU5680386A (en) 1987-04-16
NO861697L (no) 1987-03-12
NO176798B (no) 1995-02-20
ES554592A0 (es) 1988-02-16
JPS6261996A (ja) 1987-03-18
DK198086D0 (da) 1986-04-30
DE3689097T2 (de) 1994-04-21
IL78696A (en) 1991-04-15
DE214709T1 (de) 1987-10-15
IL78696A0 (en) 1986-08-31
DK198086A (da) 1987-03-12
EP0214709A2 (fr) 1987-03-18
DE3689097D1 (de) 1993-11-04
AU579467B2 (en) 1988-11-24
HK95194A (en) 1994-09-16
ES8801839A1 (es) 1988-02-16
EP0214709B1 (fr) 1993-09-29

Similar Documents

Publication Publication Date Title
NO176798C (no) Syntetisk peptid for påvisning av AIDS, fremgangsmåte for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, testsett for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, ARC og pre-AIDS tilstander
AU1380788A (en) Synthetic peptide antigens for the detection of hiv-1 infection
AU1306588A (en) Chromogenic cryptahemispherands and their use in detecting electrolytes in an aqueous test sample
DE68905313D1 (de) Enzym-immunoassay zur messung des cyclosporin-a-spiegels in vollblut-proben.
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
AU1306488A (en) Chromogenic hemispherands and their use in detecting electrolytes in an aqueous test sample
KR880700853A (ko) Aids를 유발시킬수 있는 신규 레트로비루스와 실험관내에서 그것을 검출하기 위한 수단 및 방법
DE3874605D1 (de) Mikrosonde in integrierter schalttechnik zur feststellung bestimmter gase.
GR880100180A (en) Test for the hepatite antigens and aids antigens detection
ZA87469B (en) Retrovirus capable of causing aids,means and methods for detecting it in vitro
AU590126B2 (en) Test agents and indicators for the detection of thiol groups and processes for their preparation
BG92796A (bg) Метод за откриване на антитела в кръвта,мембранна лента и мембранна батерия за провеждана на метода
AU1596188A (en) Method and means for diagnostic detection of elastase derived Bbeta-fibrino peptides
NZ220485A (en) Peptides of 4-10 amino-acids and use in test kits for detecting aids antibodies
PL262516A1 (en) Method of diagnosing by laboratory tests the infection caused in particular by htlv iii virus
FI891898A (fi) HIV-1:een liittyvät polypeptidit, diagnostiset systeemit ja analyysimenetelmät
ATE95190T1 (de) Synthetisches peptid und verfahren fuer dessen benutzung zum nachweis von antikoerpern zu htlviii, diagnose von aids und pre-aids-bedingungen und als impfstoffe.
DE3853832D1 (de) Htlv-i-peptid-antigen und testverfahren.
PT87530A (pt) Teste de diagnostic du sida base sur la mise en evidence d'une diversite de la reponse isotypique
ATE122569T1 (de) Htlv-i-peptid-antigen und testverfahren.
IE882454L (en) Novel hiv proteins and peptides useful for diagnosis or¹treatment of aids
GB2229814B (en) Detection or investigation of proteins
IL90553A0 (en) Protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses
IL80627A0 (en) Method and kit for the detection of proteins and viruses